Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2008
09/02/2008CA2283126C Method for preparing 2-thienylethylamine derivatives
09/02/2008CA2282666C Novel erythromycin derivatives, method of preparation and application as medicines
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
09/02/2008CA2271244C Pressure-mediated intracellular delivery of molecules or microparticles
09/02/2008CA2246430C Protein tyrosine phosphatases of hematopoietic cells
09/02/2008CA2243237C Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
09/02/2008CA2232527C Anti-inflammatory agent
09/02/2008CA2169696C Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
09/02/2008CA2160447C Amino(thio)ether derivatives
09/02/2008CA2131662C Improved prodrugs for enzyme mediated activation
09/02/2008CA2108927C Wilson disease gene
08/2008
08/28/2008WO2008103951A1 Methods and compounds for the targeted delivery of agents to bone for interaction therewith
08/28/2008WO2008103949A1 Modulators of pharmacokinetic properties of therapeutics
08/28/2008WO2008103926A1 Vitamin c preparation
08/28/2008WO2008103916A2 Compositions and methods for treating cancer or a neurotrophic disorder
08/28/2008WO2008103914A1 Pharmaceutical formulation
08/28/2008WO2008103899A1 Preparation and utility of non-nucleoside reverse transcriptase inhibitors
08/28/2008WO2008103852A1 Transdermal delivery of dexamethasone and promethazine
08/28/2008WO2008103818A1 Therapeutic cotinine compositions
08/28/2008WO2008103753A2 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
08/28/2008WO2008103707A1 Mono-and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile
08/28/2008WO2008103693A2 Chemical linkers with single amino acids and conjugates thereof
08/28/2008WO2008103648A1 Method of abrogating graft versus host disease via induced ship deficiency
08/28/2008WO2008103637A1 Compounds for the treatment of hepatitis c
08/28/2008WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
08/28/2008WO2008103618A1 Synthesis of novel xylosides and potential uses thereof
08/28/2008WO2008103615A1 Isoquinolines useful as inducible nitric oxide synthase inhibitors
08/28/2008WO2008103613A2 Hydroxylamine compounds and methods of their use
08/28/2008WO2008103501A1 Compounds and methods for modulating g protein-coupled receptors
08/28/2008WO2008103500A1 Thiazole derivatives as modulators of g protein-coupled receptors
08/28/2008WO2008103483A2 Marine alkaloid makaluvamines and derivatives thereof
08/28/2008WO2008103461A2 Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof
08/28/2008WO2008103431A2 Dnai - liposomes
08/28/2008WO2008103426A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
08/28/2008WO2008103421A1 Adamantanamines and neramexane salts of thiomolybdic and thiotungstic acids
08/28/2008WO2008103420A1 Compositions and methods for tranquilizing heart muscle
08/28/2008WO2008103409A2 Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis
08/28/2008WO2008103368A1 Amine polymer compositions
08/28/2008WO2008103367A2 Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
08/28/2008WO2008103353A1 Triazole compounds that modulate hsp90 activity
08/28/2008WO2008103351A2 Heterocyclic aspartyl protease inhibitors
08/28/2008WO2008103320A1 Methods of treating ophthalmic disorders with anthraquinones
08/28/2008WO2008103310A1 Substituted fused-ring compounds for inflammation and immune-related uses
08/28/2008WO2008103277A2 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008WO2008103245A2 Method of determining the weight of the coating to be applied to form a controlled release dosage form
08/28/2008WO2008103234A1 Process methods for fucoidan purification from seaweed extracts
08/28/2008WO2008103185A2 Substituted carboxamides as group i metabotropic receptor antagonists
08/28/2008WO2008103148A1 An orally-absorbed formulation for paromomycin
08/28/2008WO2008103126A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
08/28/2008WO2008103125A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
08/28/2008WO2008103060A1 A sirna sequence, vector, a molecular target for sirna reagents and vectors introduced into cells and tissues, a method of evaluating the specificity of the silencing of the mutated transcript, a method of examining the interactions of enzymes on the rnai pathway with transcripts as well as the application of the sirna sequ
08/28/2008WO2008102998A1 Compositions for improving skin conditions comprising carvacrol as an active ingredient
08/28/2008WO2008102932A1 Compositions for treating hyperproliferative vascular disorders and cancers
08/28/2008WO2008102912A1 Target protein and target gene for drug discovery, and screening method
08/28/2008WO2008102888A1 Novel pseudoglycolipid and use thereof
08/28/2008WO2008102881A1 ANALOGUE OF MAPKK NUCLEAR EXPORT INHIBITOR peumusolide A AND USE THEREOF
08/28/2008WO2008102880A1 Antimycotic patch
08/28/2008WO2008102870A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
08/28/2008WO2008102859A1 Agent for prevention and/or treatment of anxiety disorders
08/28/2008WO2008102790A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction
08/28/2008WO2008102783A1 Hair regrowth promoter
08/28/2008WO2008102777A1 Ameliorating agent for insulin resistance
08/28/2008WO2008102749A1 Heterocyclic compound
08/28/2008WO2008102716A1 Agent for treatment of adhd-related diseases
08/28/2008WO2008102669A1 Novel sugar-linked chlorin derivative and process for production thereof
08/28/2008WO2008102584A1 Novel flavanol compound and method for production thereof
08/28/2008WO2008102568A1 Bone/cartilage formation-stimulating agent
08/28/2008WO2008102563A1 Therapeutic or prophylactic agent for vasoconstriction
08/28/2008WO2008102397A2 Colchicine derivatives, process for their preparation and use in the medical field
08/28/2008WO2008102379A1 Stable sustained release formulations of fluvastatin
08/28/2008WO2008102374A1 Amorphous form of docetaxel
08/28/2008WO2008102372A1 A composition derived from fenugreek for improving physiology
08/28/2008WO2008102369A1 Novel polymorphs of erlotinib hydrochloride and method of preparation
08/28/2008WO2008102350A1 Isoflavone derivatives and uses thereof
08/28/2008WO2008102349A2 Terbinafine formulation for iontophoresis
08/28/2008WO2008102235A1 Controlled release formulations of alfuzosin
08/28/2008WO2008102210A2 Methods of playing soccer games
08/28/2008WO2008102151A1 Medical uses of glucans
08/28/2008WO2008102145A2 Process for the preparation of esomeprazole magnesium dihydrate
08/28/2008WO2008102129A1 Delta 9 - tetrahydrocannabinol processing
08/28/2008WO2008102128A2 Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
08/28/2008WO2008102086A2 Use of compositions containing at least one lignane and/or neolignane for modulating testosterone levels
08/28/2008WO2008102075A2 Novel therapeutic use for treating leukaemia
08/28/2008WO2008102037A1 Use of compounds as inhibitors for helicobacter flavodoxin
08/28/2008WO2008101995A1 Indole derivatives
08/28/2008WO2008101979A1 Quinoxaline compounds and use thereof
08/28/2008WO2008101953A1 Compounds of formula (i) as serine protease inhibitors
08/28/2008WO2008101951A1 Combination therapy using tnf and alfa-galactosyl ceramide
08/28/2008WO2008101943A1 Pharmaceutical metformin hydrochloride formulation and tablet comprising said formulation
08/28/2008WO2008101939A1 Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
08/28/2008WO2008101938A1 Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
08/28/2008WO2008101924A1 Semi-fluid food product comprising beta-glucan fibres
08/28/2008WO2008101923A1 Use of pantothenic acid derivatives for the treatment of hypophosphatemia
08/28/2008WO2008101914A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
08/28/2008WO2008101907A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
08/28/2008WO2008101905A1 Aryl carboxylic acid cyclohexyl amide derivatives
08/28/2008WO2008101886A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
08/28/2008WO2008101885A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
08/28/2008WO2008101840A1 Combination of erlotinib and mek-inhibitors for inhibiting proliferation of tumor cells
08/28/2008WO2008101824A1 Imidazo[1',5':1,6] pyrido[3,4-b]indoles derivatives and therapeutical use thereof
1 ... 3109 3110 3111 3112 3113 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 ... 7860